Irati Macaya

729 total citations
7 papers, 132 citations indexed

About

Irati Macaya is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Irati Macaya has authored 7 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Irati Macaya's work include Genetic factors in colorectal cancer (2 papers), RNA modifications and cancer (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Irati Macaya is often cited by papers focused on Genetic factors in colorectal cancer (2 papers), RNA modifications and cancer (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Irati Macaya collaborates with scholars based in Spain, Australia and Netherlands. Irati Macaya's co-authors include Diego Arango, Sarah Bazzocco, Josipa Bilić, Simó Schwartz, Fernando Cartón‐García, Higinio Dopeso, Santiago Ramón y Cajal, Stefania Landolfi, Paulo Rodrigues and Sven C.D. van IJzendoorn and has published in prestigious journals such as Oncogene, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Irati Macaya

7 papers receiving 131 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irati Macaya Spain 6 75 30 30 23 20 7 132
Oscar Pellón-Cárdenas United States 9 78 1.0× 41 1.4× 13 0.4× 26 1.1× 39 1.9× 9 139
Kenia Gandia United States 2 69 0.9× 34 1.1× 12 0.4× 10 0.4× 14 0.7× 2 155
Silvia Lechner Austria 6 106 1.4× 13 0.4× 61 2.0× 95 4.1× 7 0.3× 8 221
Zhiqin Huang China 9 135 1.8× 16 0.5× 18 0.6× 29 1.3× 15 0.8× 20 186
Subbaiah Chary Nimmagadda Germany 9 120 1.6× 40 1.3× 16 0.5× 12 0.5× 22 1.1× 13 172
Sally Cottrell United Kingdom 6 68 0.9× 97 3.2× 15 0.5× 31 1.3× 30 1.5× 7 174
Ferran Fece de la Cruz United States 5 105 1.4× 42 1.4× 9 0.3× 10 0.4× 32 1.6× 7 137
Erin M. Coyne United States 5 108 1.4× 30 1.0× 21 0.7× 11 0.5× 21 1.1× 9 147
Benjamin Brady Australia 7 81 1.1× 61 2.0× 22 0.7× 17 0.7× 20 1.0× 12 145
Lisa Deng United States 7 90 1.2× 38 1.3× 11 0.4× 9 0.4× 21 1.1× 10 194

Countries citing papers authored by Irati Macaya

Since Specialization
Citations

This map shows the geographic impact of Irati Macaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irati Macaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irati Macaya more than expected).

Fields of papers citing papers by Irati Macaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irati Macaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irati Macaya. The network helps show where Irati Macaya may publish in the future.

Co-authorship network of co-authors of Irati Macaya

This figure shows the co-authorship network connecting the top 25 collaborators of Irati Macaya. A scholar is included among the top collaborators of Irati Macaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irati Macaya. Irati Macaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rodríguez‐Remírez, María, Inés López, Irati Macaya, et al.. (2024). Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation. Molecular Cancer. 23(1). 78–78. 7 indexed citations
2.
Cartón‐García, Fernando, Higinio Dopeso, Irati Macaya, et al.. (2022). Myosin Vb as a tumor suppressor gene in intestinal cancer. Oncogene. 41(49). 5279–5288. 2 indexed citations
3.
Serrano‐Candelas, Eva, Erola Ainsua‐Enrich, Paulo Rodrigues, et al.. (2018). Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth. Molecular Oncology. 12(8). 1383–1397. 12 indexed citations
4.
Dopeso, Higinio, Paulo Rodrigues, Josipa Bilić, et al.. (2017). Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer. British Journal of Cancer. 118(1). 106–116. 19 indexed citations
5.
Andretta, Elena, Fernando Cartón‐García, Águeda Martínez‐Barriocanal, et al.. (2017). Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer. Scientific Reports. 7(1). 41576–41576. 11 indexed citations
6.
Bazzocco, Sarah, Higinio Dopeso, Fernando Cartón‐García, et al.. (2015). Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. Clinical Cancer Research. 21(16). 3695–3704. 30 indexed citations
7.
Cartón‐García, Fernando, Arend W. Overeem, Sarah Bazzocco, et al.. (2015). Myo5b knockout mice as a model of microvillus inclusion disease. Scientific Reports. 5(1). 12312–12312. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026